Sommetrics Announces Expansion of Leadership Team with New Senior Vice President of Marketing and Vice President of Bioinformatics
San Diego, June 21, 2016 – Sommetrics, Inc., a company focused on providing products and services that improve sleep quality, announces the hiring of Sarah Polk as Senior Vice President of Marketing and Stephen Maine as Vice President of Bioinformatics to facilitate the advancement of the company’s cNEP® (continuous negative external pressure) technology, products and services focused on obstructive sleep apnea (OSA) and sedation-related apneas.
Sommetrics Announces Publication of the Landmark cNEP Airway Study Showing A Reduction in Respiratory Impairment During Routine Colonoscopy
San Diego, CA, May 10, 2016 – Sommetrics, Inc., a company focused on providing products and services that improve the quality of sleep, today announced the publication of study results demonstrating that the company’s cNEP® Airway System significantly reduces respiratory impairment during screening colonoscopy. The peer-reviewed study results were published online in the journal Endoscopy, a leading GI endoscopy journal.
Sommetrics™ Expands Leadership and adds Prominent Medical Advisors
San Diego, March 10, 2016 – Sommetrics, a company focused on providing products and services that improve the quality of sleep, announces the appointment of Paul Edwards as Senior VP of Engineering and Manufacturing. Mr. Edwards joins Sommetrics from SeQual Technologies, where he most recently served as VP of Engineering and was responsible for new product development and engineering for portable lightweight oxygen delivery systems.
Sommetrics Announces FDA Clearance to Market its cNEP™ External Airway Management Device
San Diego, CA January 26, 2016 – Sommetrics, a medical technology company focused on developing products for assessing and managing sleep problems, announced FDA clearance to market its cNEP™ Airway Management system as an aid for maintaining the patency of the upper airway in spontaneously breathing adults undergoing medical procedures less than 2 hours in duration. This device is intended for use in cases of mild to moderate sedation with non-propofol drugs.
Sommetrics Strengthens its Management Team
San Diego, March 25, 2015 – Sommetrics announced that it has enhanced its organizational capabilities with the appointment of three executives to its management team and the expansion of one executive’s role. “I am very pleased to have the opportunity to add several accomplished individuals to our management team,” said Dr. Richard Rose, Chief Executive Officer. “Their experience and skill will make significant contributions in bringing cNEP® technology to market.”
Sommetrics Raises an Additional $5.2 Million in Expansion of Series B Round
San Diego, February 12, 2015 – Sommetrics, formerly 5i Sciences, announced it has raised an additional $5.2 million in an expansion of its Series B financing. These funds will be used to further the development of the Company’s proprietary cNEP™ products for the treatment of sleep apnea and related conditions.
Sommetrics Announces New Name and Appoints Dr. Jon-Erik Holty to Medical Advisory Board
San Diego, November 11, 2014 – Sommetrics, formerly 5i Sciences, announces a new name to emphasize its focus on measuring and managing sleep disorders related to airway obstruction. The Company also announced the appointment of Jon-Erik Holty, M.D. as a Senior Consultant and member of the Medical Advisory Board.
5i Sciences Announces Appointment of a Senior Healthcare Consultant and Successful Financing
San Diego – July 22, 2014 – 5i Sciences announces both the appointment of Molly Coye, M.D., M.P.H. as a Senior Consultant and the completion of a Series B financing to further development of its products in anesthesia care and sleep medicine.
5i Sciences Hires General Manager for Acute Care Product Group, Announces Favorable Clinical Results
San Diego, February 21, 2014 – 5i Sciences appoints Jan Barker as General Manager of its acute care product group and announces favorable results from a completed study in adults receiving sedation for a commonly performed medical procedure.
5i Sciences Announces Appointment of New Directors and Successful Financing
San Diego, January 28, 2014 – 5i Sciences appoints three new Directors to its Board, and raises $2 MM to further development of its products in anesthesia care and sleep medicine.